1,4-Dideoxy-1,4-epithio-D-ribitol

CAS No. 190315-43-6

1,4-Dideoxy-1,4-epithio-D-ribitol( —— )

Catalog No. M37903 CAS No. 190315-43-6

1,4-Dideoxy-1,4-epithio-D-ribitol is a purine nucleoside analog that targets malignant tumors of the inert lymphatic system and possesses a broad spectrum of antitumor activity.1,4-Dideoxy-1,4-epithio-D-ribitol induces apoptosis through inhibition of DNA synthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 In Stock
5MG 409 In Stock
10MG 604 In Stock
25MG 908 In Stock
50MG 1251 In Stock
100MG 1647 In Stock
500MG 3312 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1,4-Dideoxy-1,4-epithio-D-ribitol
  • Note
    Research use only, not for human use.
  • Brief Description
    1,4-Dideoxy-1,4-epithio-D-ribitol is a purine nucleoside analog that targets malignant tumors of the inert lymphatic system and possesses a broad spectrum of antitumor activity.1,4-Dideoxy-1,4-epithio-D-ribitol induces apoptosis through inhibition of DNA synthesis.
  • Description
    (2R,3S,4R)-2-(Hydroxymethyl)tetrahydrothiophene-3,4-diol is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    DNA/RNA Synthesis | Apoptosis | Nucleoside Antimetabolite/Analog
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    190315-43-6
  • Formula Weight
    150.2
  • Molecular Formula
    C5H10O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(O)[C@@H]1[C@@H](O)[C@@H](O)CS1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.?
molnova catalog
related products
  • CCG-203971

    CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.

  • Helicid

    Helicid is a medicine available in a number of countries worldwide.

  • RI-1

    RI-1 is a RAD51 inhibitor with IC50 ranging from 5 to 30μM.